We consider that many inflammatory mediators are present in various quantities in serum during the acute disease phase associated with initial treatment of EGPA; these mediators might therefore out-compete IVIG and suppress the differentiation of Treg (FOXP3+CD4+) cells. This evidence concerns the gene FOXP3 and eosinophilic granulomatosis with polyangiitis.